{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T04:02:16Z","timestamp":1780718536705,"version":"3.54.1"},"reference-count":39,"publisher":"Japanese Society of Internal Medicine","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026]]},"DOI":"10.2169\/internalmedicine.7579-26","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T22:09:25Z","timestamp":1780524565000},"source":"Crossref","is-referenced-by-count":0,"title":["Prevention Strategies for Inflammatory Bowel Disease"],"prefix":"10.2169","author":[{"given":"Yuji","family":"Naito","sequence":"first","affiliation":[{"name":"Human Immunology and Nutrition Science, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Japan"},{"name":"Molecular Gastroenterology and Hepatology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiko","family":"Uchiyama","sequence":"additional","affiliation":[{"name":"Molecular Gastroenterology and Hepatology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohisa","family":"Takagi","sequence":"additional","affiliation":[{"name":"Molecular Gastroenterology and Hepatology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Yamazaki M, Chung H, Xu Y, Qiu H. Trends in the prevalence and incidence of ulcerative colitis in Japan and the US. Int J Colorectal Dis 38: 135, 2023.","DOI":"10.1007\/s00384-023-04417-6"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2. Tsutsui A, Murakami Y, Nishiwaki Y, et al. Nationwide estimates of patient numbers and prevalence rates of ulcerative colitis and Crohn's disease in Japan in 2023. J Gastroenterol 60: 1513-1522. 10.1007\/s00535-025-02295-z, 2025.","DOI":"10.1007\/s00535-025-02295-z"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Murakami Y, Nishiwaki Y, Oba MS, et al. Estimated prevalence of ulcerative colitis and Crohn's disease in Japan in 2014: an analysis of a nationwide survey. J Gastroenterol 54: 1070-1077, 2019.","DOI":"10.1007\/s00535-019-01603-8"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Nakajo K, Yamazaki M, Chung H, Xu Y, Qiu H. Trends in the prevalence and incidence of Crohn's disease in Japan and the United States. Int J Colorectal Dis 39: 61, 2024.","DOI":"10.1007\/s00384-024-04636-5"},{"key":"5","doi-asserted-by":"publisher","unstructured":"5. Hracs L, Windsor JW, Gorospe J, et al. Global evolution of inflammatory bowel disease across epidemiologic stages. Nature 642: 458-466, 2025.","DOI":"10.1038\/s41586-025-08940-0"},{"key":"6","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1186\/s12889-025-24009-z","volume":"25","author":"K Yang","year":"2025","unstructured":"6. Yang K, Zhang C, Gong R, et al. From west to east: dissecting the global shift in inflammatory bowel disease burden and projecting future scenarios. BMC Public Health 25: 2696, 2025.","journal-title":"BMC Public Health","ISSN":"https:\/\/id.crossref.org\/issn\/1471-2458","issn-type":"print"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Park J, Cheon JH. Incidence and prevalence of inflammatory bowel disease across Asia. Yonsei Med J 62: 99-108, 2021.","DOI":"10.3349\/ymj.2021.62.2.99"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Levine A, Koletzko S, Turner D, et al. ESPGHAN revised porto criteria for the diagnosis of inflammatory bowel disease in children and adolescents. J Pediatr Gastroenterol Nutr 58: 795-806, 2014.","DOI":"10.1097\/MPG.0000000000000239"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Uhlig HH, Charbit-Henrion F, Kotlarz D, et al. Clinical genomics for the diagnosis of monogenic forms of inflammatory bowel disease: A position paper from the paediatric IBD Porto group of European society of paediatric gastroenterology, hepatology and nutrition IBD. J Pediatr Gastroenterol Nutr 72: 456-473, 2021.","DOI":"10.1097\/MPG.0000000000003017"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Nambu R, Warner N, Mulder DJ, et al. A systematic review of monogenic inflammatory bowel disease. Clin Gastroenterol Hepatol 20: e653-e663, 2022.","DOI":"10.1016\/j.cgh.2021.03.021"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Ouahed JD, Griffith A, Collen LV, Snapper SB. Breaking down barriers: epithelial contributors to monogenic IBD pathogenesis IBD. Inflam Bowel Dis 30: 1189-1206, 2024.","DOI":"10.1093\/ibd\/izad319"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Umeno J, Esaki M, Hirano A, et al. Clinical features of chronic enteropathy associated with SLCO2A1 gene: a new entity clinically distinct from Crohn's disease. J Gastroenterol 53: 907-915, 2018.","DOI":"10.1007\/s00535-017-1426-y"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Umeno J, Esaki M, Uchida K, Matsumoto T. Chronic enteropathy associated with SLCO2A1 gene. Inflamm Intest Dis 10: 193-203, 2025.","DOI":"10.1159\/000546888"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Nakase H, Wagatsuma K, Kobayashi T, et al. Involvement of Mediterranean fever gene mutations in colchicine-responsive enterocolitis: a retrospective cohort study. EBiomedicine 110: 2024.","DOI":"10.2139\/ssrn.4819257"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Chen J, Sun Y, Dan L, et al. Composition of plant-based diets and the incidence and prognosis of inflammatory bowel disease: a multinational retrospective cohort study. Lancet Reg Health Eur 52: 2025.","DOI":"10.1016\/j.lanepe.2025.101264"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Satija A, Bhupathiraju SN, Rimm EB, et al. Plant-based dietary patterns and incidence of type 2 diabetes in US men and women: results from three prospective cohort studies. PLOS Med 13: e1002039, 2016.","DOI":"10.1371\/journal.pmed.1002039"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Aljuraiban GS, Gibson R, Al-Freeh L, et al. Associations among plant-based dietary indexes, the dietary inflammatory index, and inflammatory potential in female college students in Saudi Arabia: a cross-sectional study. J Acad Nutr Diet 122: 771-785.e8, 2022.","DOI":"10.1016\/j.jand.2021.08.111"},{"key":"18","doi-asserted-by":"publisher","unstructured":"18. Lo CH, Lochhead P, Khalili H, et al. Dietary inflammatory potential and risk of Crohn's disease and ulcerative colitis. Gastroenterology 159: 873-883.e1, 2020.","DOI":"10.1053\/j.gastro.2020.05.011"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Tabung FK, Smith-Warner SA, Chavarro JE, et al. Development and validation of an empirical dietary inflammatory index. J Nutr 146: 1560-1570, 2016.","DOI":"10.3945\/jn.115.228718"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Tabung FK, Smith-Warner SA, Chavarro JE, et al. An empirical dietary inflammatory pattern score enhances prediction of circulating inflammatory biomarkers in adults. J Nutr 147: 1567-1577, 2017.","DOI":"10.3945\/jn.117.248377"},{"key":"21","doi-asserted-by":"publisher","unstructured":"21. Ananthakrishnan AN, Khalili H, Konijeti GG, et al. Long-term intake of dietary fat and risk of ulcerative colitis and Crohn's disease. Gut 63: 776-784, 2014.","DOI":"10.1136\/gutjnl-2013-305304"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Takeuchi T, Kameyama K, Miyauchi E, et al. Fatty acid overproduction by gut commensal microbiota exacerbates obesity. Cell Metab 35: 361-375.e9, 2023.","DOI":"10.1016\/j.cmet.2022.12.013"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Higashimura Y, Tanaka Y, Takagi T, et al. Trans-unsaturated fatty acid activates NLRP3 inflammasome in macrophages and exacerbates intestinal inflammation in mice. Biochem Biophys Res Commun 529: 243-250, 2020.","DOI":"10.1016\/j.bbrc.2020.06.005"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Deng M, Dan L, Ye S, et al. Higher dietary fibre intake is associated with lower risk of inflammatory bowel disease: prospective cohort study. Aliment Pharmacol Ther 58: 516-525, 2023.","DOI":"10.1111\/apt.17649"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Ananthakrishnan AN, Khalili H, Konijeti GG, et al. A prospective study of long-term intake of dietary fibre and risk of Crohn's disease and ulcerative colitis. Gastroenterology 145: 970-977, 2013.","DOI":"10.1053\/j.gastro.2013.07.050"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Seto T, Grondin JA, Khan WI. Food additives: emerging detrimental roles on gut health. FASEB J 39: e70810, 2025.","DOI":"10.1096\/fj.202500737R"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Rondinella D, Raoul PC, Valeriani E, et al. The detrimental impact of ultra-processed foods on the human gut microbiome and gut barrier. Nutrients 17: 859, 2025.","DOI":"10.3390\/nu17050859"},{"key":"28","unstructured":"28. Narula N, Wong ECL, Dehghan M, et al. Association of ultra-processed food intake with risk of inflammatory bowel disease: prospective cohort study. BMJ 374: n1554, 2021."},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Lo CH, Khandpur N, Rossato SL, et al. Ultra-processed foods and risk of Crohn's disease and ulcerative colitis: a prospective cohort study. Clin Gastroenterol Hepatol 20: e1323-e1337, 2022.","DOI":"10.1016\/j.cgh.2021.08.031"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Satokari R. High intake of sugar and the balance between pro- and anti-inflammatory gut bacteria. Nutrients 12: 1348, 2020.","DOI":"10.3390\/nu12051348"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Khademi Z, Milajerdi A, Larijani B, Esmaillzadeh A. Dietary intake of total carbohydrates, sugar and sugar-sweetened beverages, and risk of inflammatory bowel disease: a systematic review and meta-analysis of prospective cohort studies. Front Nutr 8: 707795, 2021.","DOI":"10.3389\/fnut.2021.707795"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Maniyar I, Jajoo A, Brewer GG, et al. Dietary sugar and sweetened beverage intake increases inflammatory bowel disease risk: a systematic review and meta-analysis. U Eur Gastroenterol J 13: 1379-1409, 2025.","DOI":"10.1002\/ueg2.70047"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Lee SH, Turpin W, Espin-Garcia O, et al. Crohn's, colitis Canada genetics environment microbial project research C. Anti-microbial antibody response is associated with future onset of Crohn's disease independent of biomarkers of altered gut barrier function, subclinical inflammation, and genetic risk. Gastroenterology 161: 1540-151, 2021.","DOI":"10.1053\/j.gastro.2021.07.009"},{"key":"34","unstructured":"34. Xue M, Leibovitzh H, Jingcheng S, et al. Environmental factors associated with risk of Crohn's disease development in the Crohn's and colitis Canada - genetic, environmental, microbial project. Clin Gastroenterol Hepatol 22: 1889-1897, 2024."},{"key":"35","unstructured":"35. Raygoza Garay JA, Turpin W, Lee SH, et al. Gut microbiome composition is associated with future onset of Crohn's disease in healthy first-degree relatives. Gastroenterology 165: 670-681, 2023."},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Sun Y, Yuan S, Chen X, et al. The contribution of genetic risk and lifestyle factors in the development of adult-onset inflammatory bowel disease: A prospective cohort study. Am J Gastroenterol 118: 511-522, 2023.","DOI":"10.14309\/ajg.0000000000002180"},{"key":"37","doi-asserted-by":"publisher","unstructured":"37. Kuwada T, Shiokawa M, Kodama Y, et al. Identification of an anti-integrin alphavbeta6 autoantibody in patients with ulcerative colitis. Gastroenterology 160: 2383-2394, 2021.","DOI":"10.1053\/j.gastro.2021.02.019"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Sawahashi M, Kakuta Y, Naito T, et al. Autoantibodies against endothelial protein C receptor and integrin \u03b1v\u03b26 predict the development of ulcerative colitis. J Gastroenterol 60: 1108-1117, 2025.","DOI":"10.1007\/s00535-025-02263-7"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Livanos AE, Dunn A, Fischer J, et al. Anti-integrin alphavbeta6 autoantibodies are a novel biomarker that antedate ulcerative colitis. Gastroenterology 164: 619-629, 2023.","DOI":"10.1016\/S0016-5085(23)01379-3"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/advpub\/0\/advpub_7579-26\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T03:33:31Z","timestamp":1780716811000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/advpub\/0\/advpub_7579-26\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":39,"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.7579-26","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"7579-26"}}